These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7877257)
41. Genomic structure of the human tetratricopeptide repeat-containing gene, TTC4, from chromosome region 1p31 and mutation analysis in breast cancers. Su G; Casey G; Cowell JK Int J Mol Med; 2000 Feb; 5(2):197-200. PubMed ID: 10639601 [TBL] [Abstract][Full Text] [Related]
42. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Sato T; Saito H; Swensen J; Olifant A; Wood C; Danner D; Sakamoto T; Takita K; Kasumi F; Miki Y Cancer Res; 1992 Mar; 52(6):1643-6. PubMed ID: 1540973 [TBL] [Abstract][Full Text] [Related]
43. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998 [TBL] [Abstract][Full Text] [Related]
45. NF2: the wizardry of merlin. Xiao GH; Chernoff J; Testa JR Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860 [TBL] [Abstract][Full Text] [Related]
46. Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers. Yaegashi S; Sachse R; Ohuchi N; Mori S; Sekiya T Jpn J Cancer Res; 1995 Oct; 86(10):929-33. PubMed ID: 7493911 [TBL] [Abstract][Full Text] [Related]
47. Neurofibromatosis 2 gene in human colorectal cancer. Rustgi AK; Xu L; Pinney D; Sterner C; Beauchamp R; Schmidt S; Gusella JF; Ramesh V Cancer Genet Cytogenet; 1995 Oct; 84(1):24-6. PubMed ID: 7497438 [TBL] [Abstract][Full Text] [Related]
48. Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Zhang N; Zhao Z; Long J; Li H; Zhang B; Chen G; Li X; Lv T; Zhang W; Ou X; Xu A; Huang J Oncol Rep; 2017 Dec; 38(6):3650-3658. PubMed ID: 29130106 [TBL] [Abstract][Full Text] [Related]
49. Exon scanning for mutation of the NF2 gene in schwannomas. Jacoby LB; MacCollin M; Louis DN; Mohney T; Rubio MP; Pulaski K; Trofatter JA; Kley N; Seizinger B; Ramesh V Hum Mol Genet; 1994 Mar; 3(3):413-9. PubMed ID: 8012353 [TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Englefield P; Foulkes WD; Campbell IG Br J Cancer; 1994 Nov; 70(5):905-7. PubMed ID: 7947096 [TBL] [Abstract][Full Text] [Related]
52. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Bianchi AB; Mitsunaga SI; Cheng JQ; Klein WM; Jhanwar SC; Seizinger B; Kley N; Klein-Szanto AJ; Testa JR Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10854-8. PubMed ID: 7479897 [TBL] [Abstract][Full Text] [Related]
53. The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms. Haase VH; Trofatter JA; MacCollin M; Tarttelin E; Gusella JF; Ramesh V Hum Mol Genet; 1994 Mar; 3(3):407-11. PubMed ID: 8012352 [TBL] [Abstract][Full Text] [Related]
54. Deletion of Gerardo-Ramírez M; Giam V; Becker D; Groth M; Hartmann N; Morrison H; May-Simera HL; Radsak MP; Marquardt JU; Galle PR; Herrlich P; Straub BK; Hartmann M Cells; 2023 Apr; 12(9):. PubMed ID: 37174657 [TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene. Watkins D; Ruttledge MH; Sarrazin J; Rangaratnam S; Poisson M; Delattre JY; Rouleau GA Cancer Genet Cytogenet; 1996 Nov; 92(1):73-8. PubMed ID: 8956876 [TBL] [Abstract][Full Text] [Related]
56. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Hoang-Xuan K; Merel P; Vega F; Hugot JP; Cornu P; Delattre JY; Poisson M; Thomas G; Delattre O Int J Cancer; 1995 Feb; 60(4):478-81. PubMed ID: 7829260 [TBL] [Abstract][Full Text] [Related]
57. The mouse homologue of the neurofibromatosis type 2 gene is highly conserved. Claudio JO; Marineau C; Rouleau GA Hum Mol Genet; 1994 Jan; 3(1):185-90. PubMed ID: 8162023 [TBL] [Abstract][Full Text] [Related]
58. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946 [TBL] [Abstract][Full Text] [Related]
59. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Arakawa H; Hayashi N; Nagase H; Ogawa M; Nakamura Y Hum Mol Genet; 1994 Apr; 3(4):565-8. PubMed ID: 8069299 [TBL] [Abstract][Full Text] [Related]
60. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Benhamouche S; Curto M; Saotome I; Gladden AB; Liu CH; Giovannini M; McClatchey AI Genes Dev; 2010 Aug; 24(16):1718-30. PubMed ID: 20675406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]